Market Report

Life Science Research Tools Market Assessment

July 31, 2021

72 pages

ABSTRACT

The fourth edition of this report provides an overview of the life sciences research tools market from 2013 to 2021. Life sciences research tools companies offer instruments, reagents and services to academic, BioPharma, applied market and (non-IVD) clinical customers. This market is consolidated, with top vendors including Agilent, Bio-Rad, Illumina, Life Technologies*, MilliporeSigma, and Thermo Fisher representing the majority of sales; however, mid-size players (e.g., Luminex, NanoString) and smaller emerging players are highlighted and included in this report as well (e.g., Oxford Nanopore, Quanterix, Seahorse Biosciences***).

As in previous versions, we carefully triangulated market growth with past and forecasted organic growth from keys players, many of which have experienced growth driven by acquisition. As a result, segmenting the market by technology, we estimate that the life science research tools market will reach $52.5B in 2017, and is expected to grow ~5% p.a. in the next 4 years. These figures are in contrast with other reports on individual technologies that report bullish growth rates of 5%-20% for many technologies. Our analysis confirms that within academia, growth will continue to be strong in emerging markets (e.g., China, India) offset by weakness in academic funding in developed countries (e.g., Japan, Europe). With that said, our analysis confirms that applied markets (such as non-IVD clinical / LDT’s, forensics or AgBio customers) might experience double digit growth for many technologies. This report evaluates which technologies are expected to capture (e.g., NGS, mass spectrometry) and lose (e.g., PCR) relative market share.

Macro Drivers:
  • Growth in APAC
  • Strength in biopharma and applied markets
  • New instruments driving upgrade cycles and revenue growth
Macro Moderators:
  • Funding pressure in the developing world
  • Commoditization of some products
  • Pricing Pressure
  • Miniaturization

For each of these 36 subsegments, we present an analysis detailing sales of instruments and reagents for 2018, 2021, and 2024. In addition, we detail market drivers (e.g., increased government funding in emerging markets) and moderators (e.g., pricing pressure for some technologies), market trends (e.g., interest in cell therapies), a high-level end-customer breakdown (academic / government customers, biopharma / CROs, clinical non-IVD, and applied markets) and key competitors.

All data are based on manufacturer sales as publicly reported and DeciBio research and analysis.

Pure Genomics Technologies

  • PCR
  • qPCR
  • Digital PCR
  • Microarrays
  • CE sequencing
  • NGS / 3GS
  • Molecular biology

Pure Proteomics Technologies

  • Western blot
  • ELISA
  • Protein microarrays
  • Other immunoassays
  • Protein production
  • General antibodies

Pure Cell Biology Technologies

  • Flow cytometry
  • Whole cell analysis
  • High content imaging
  • Spatial omics
  • Microscopy
  • Cell culture equipment
  • Cells and tissues
  • Transfection and electroporation
  • Media and sera
  • Basic reagents
  • Cell-based assay discovery services

Other Analytical Technologies

  • Chromatography
  • Mass spec
  • Structural analysis
  • In vivo study
  • Spectroscopy
  • Label-free technologies

Other Supplies and Technologies

  • Lab supplies and disposables
  • Lab automation
  • Glassware
  • Sample preparation
  • LIMS
  • Magnetic bead

Authors

Precision Medicine is evolving at a rapid pace

Discover how we can help

Contact Us
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.